Tomoko Katsube
Shimane University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomoko Katsube.
Alimentary Pharmacology & Therapeutics | 2000
Kyoichi Adachi; Tomoko Katsube; Akira Kawamura; T. Takashima; M. Yuki; Kazutoshi Amano; Shunji Ishihara; Ryo Fukuda; Makoto Watanabe; Yoshikazu Kinoshita
CYP2C19 has an important role in the catabolism of several proton pump inhibitors. However, the relative contribution of CYP2C19‐mediated metabolism varies among the different proton pump inhibitors.
Journal of Gastroenterology and Hepatology | 2001
Kyoichi Adachi; Hirofumi Fujishiro; Tomoko Katsube; Mika Yuki; Masahiro Ono; Akira Kawamura; Mohammad Azharul Karim Rumi; Makoto Watanabe; Yoshikazu Kinoshita
Nocturnal gastric acid breakthrough (NAB) is defined as an intragastric pH < 4.0 lasting more than 1 h during the night in patients taking a proton pump inhibitor (PPI). Gastroesophageal reflux disease (GERD) patients with nocturnal gastroesophageal acid reflux accompanied by NAB are thought to be refractory to PPI treatment. The aim of this study was to endoscopically identify the patients with predominant nocturnal gastroesophageal acid reflux.
Journal of Gastroenterology and Hepatology | 2001
Kazutoshi Amano; Kyoichi Adachi; Tomoko Katsube; Makoto Watanabe; Yoshikazu Kinoshita
Background and Aims: The pathogenetic mechanism responsible for the increased prevalence of reflux esophagitis in the elderly remains controversial. The aim of this study was to determine if an increased occurrence of hiatus hernia (HH) and/or a lower rate of gastric mucosal atrophy (GMA) are the main causes of the increased prevalence of reflux esophagitis in elderly patients.
Journal of Gastroenterology and Hepatology | 2001
Akira Kawamura; Kyoichi Adachi; Toshiharu Takashima; Mitsuyoshi Murao; Tomoko Katsube; Mika Yuki; Makoto Watanabe; Yoshikazu Kinoshita
Aim: To investigate the prevalence of functional dyspepsia and Helicobacter pylori infection and their relationship in a Japanese population.
Alimentary Pharmacology & Therapeutics | 2000
Tomoko Katsube; Kyoichi Adachi; Akira Kawamura; Kazutoshi Amano; Yasushi Uchida; Makoto Watanabe; Yoshikazu Kinoshita
Nocturnal gastric acid breakthrough is defined as night‐time periods when gastrin pH falls below 4.0 for greater than 1h during administration of a proton pump inhibitor. This phenomenon is a serious problem for patients who require strict control of their gastric acid secretions.
Journal of Gastroenterology and Hepatology | 1999
Kazuya Hirakawa; Kyoichi Adachi; Kazutoshi Amano; Tomoko Katsube; Shunji Ishihara; Ryo Fukuda; Yukimasa Yamashita; Shunichi Shiozawa; Makoto Watanabe; Yoshikazu Kinoshita
Background : Non‐ulcer dyspepsia (NUD) is one of the most frequently encountered disorders in general practice in Western countries. The prevalence of this disorder in the Japanese, however, has not been fully investigated. This study is designed to clarify the characteristics and prevalence of dyspepsia in the Japanese.
Journal of Gastroenterology and Hepatology | 2003
Kyoichi Adachi; Tomoyuki Hashimoto; Naoharu Hamamoto; Kazuya Hirakawa; Masatoshi Niigaki; Tatsuya Miyake; Hiroyuki Taniura; Masahiro Ono; Takekazu Kaji; Hiroshi Suetsugu; Junko Yagi; Yoshinori Komazawa; Takafumi Mihara; Tomoko Katsube; Hirofumi Fujishiro; Toshihiro Shizuku; Shuzo Hattori; Shun Yamamoto; Yoshikazu Kinoshita
Background and Aim: Rabeprazole has a faster onset of antisecretory activity than omeprazole and lansoprazole. The aim of the present study was to clarify whether there is any difference in the speed of symptom relief in patients with reflux esophagitis following the administration of these three proton pump inhibitors (PPI).
Journal of Clinical Gastroenterology | 1999
Noriyuki Arima; Kyoichi Adachi; Tomoko Katsube; Kazutoshi Amano; Shunji Ishihara; Makoto Watanabe; Yoshikazu Kinoshita
Since endoscopic treatment has been evaluated and become established as treatment for early gastric cancer, metachronous recurrence has become a major problem. In this report, predictive factors for recurrence were studied using the Kaplan-Meier method and Coxs proportional hazards regression model in 76 patients who received endoscopic treatment. There were 48 men and 28 women age 69.6 +/- 8.3 years (mean +/- standard deviation), 5 of whom had synchronous multiple lesions and 71 who had a single lesion found during the initial endoscopic treatment. In all patients, periodic follow-ups were performed by endoscopy for more than 2 years after treatment. Helicobacter pylori infection was assessed in 55 of the 76 patients, and proved positive in 43 and negative in 12. Metachronous recurrence was detected significantly more frequently in patients whose synchronous multiple lesions were found during the initial treatment. In addition, age affected the recurrence positively. However, gender and H. pylori infection had no significant relationship with metachronous recurrence.
Journal of Gastroenterology and Hepatology | 2006
Tomoko Katsube; Kyoichi Adachi; Kenji Furuta; Masaharu Miki; Tomoo Fujisawa; Takane Azumi; Yoshinori Kushiyama; Hideaki Kazumori; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Background: Gastroesophageal reflux occurs mainly during the daytime in patients with Los Angeles grade A esophagitis, but predominantly during the night in patients with grade C and D esophagitis. The purpose of the present paper was to investigate whether this difference in the pattern of gastroesophageal reflux influences the circumferential localization of erosions in the esophageal wall.
Journal of Gastroenterology and Hepatology | 2001
Hirofumi Fujishiro; Kyoichi Adachi; Akira Kawamura; Tomoko Katsube; Masahiro Ono; Mika Yuki; Kazutoshi Amano; Shunji Ishihara; Yoshikazu Kinoshita
Reflux esophagitis is caused by esophageal motor dysfunction in patients with sufficient gastric acid secretion. Helicobacter pylori causes atrophic gastritis and influences gastric acid secretion. Hiatus hernia (HH) of the esophagus causes motor dysfunction in the lower esophagus. Therefore, this study aimed to test whether H. pylori infection, gastric mucosal atrophy and HH are predictive factors for reflux esophagitis.